These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 13681211

  • 21. [ON THE EFFECT OF ANTIHISTAMINICS ON AMINES IN THE LIVING BODY AND THE ACTION OF MONOAMINE OXIDASE INHIBITORS ON URINARY CATECHOLAMINES].
    KAWAKAMI Y, SATO M, NARIMIYA S.
    Arerugi; 1964 Mar; 13():143-5. PubMed ID: 14138413
    [No Abstract] [Full Text] [Related]

  • 22. [Synaptosomal transport of cerebral tryptophan and tyrosine. Stimulation of the rate of uptake after administration of reserpine or monoamine oxidases inhibitor].
    Belin MF, Chouvet G, Pujol JF.
    Biochem Pharmacol; 1974 Feb 01; 23(3):587-97. PubMed ID: 4822744
    [No Abstract] [Full Text] [Related]

  • 23. CIRCADIAN RHYTHM IN PINEAL SEROTONIN: EFFECT OF MONOAMINE OXIDASE INHIBITION AND RESERPINE.
    SNYDER SH, AXELROD J.
    Science; 1965 Jul 30; 149(3683):542-4. PubMed ID: 14325156
    [Abstract] [Full Text] [Related]

  • 24. Neurochemical correlates of behavior II. Correlation of brain monoamine oxidase activity with behavioural changes after iproniazid and 5-hydroxytryptophan administration.
    APRISON MH, FERSTER CB.
    J Neurochem; 1961 Mar 30; 6():350-7. PubMed ID: 13683915
    [No Abstract] [Full Text] [Related]

  • 25. Action of reserpine and monoamine oxidase inhibitors on the urinary excretion of catecholamines in the rat.
    BICKEL MH, CARPI A, BOVET D.
    Helv Physiol Pharmacol Acta; 1961 Mar 30; 19():279-84. PubMed ID: 13868969
    [No Abstract] [Full Text] [Related]

  • 26. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.
    Grahame-Smith DG.
    J Neurochem; 1971 Jun 30; 18(6):1053-66. PubMed ID: 4254940
    [No Abstract] [Full Text] [Related]

  • 27. [Monoamine liberators and monoamine oxidase inhibitors].
    LEUSEN I.
    Psychiatr Neurol (Basel); 1960 Jul 30; 140():154-64. PubMed ID: 13761295
    [No Abstract] [Full Text] [Related]

  • 28. Chick brain amines: normal levels and effect of reserpine and monoamine oxidase inhibitors.
    Pscheidt GR, Himwich HE.
    Prog Brain Res; 1965 Jul 30; 16():245-9. PubMed ID: 5831122
    [No Abstract] [Full Text] [Related]

  • 29. [STUDIES OF THE URINARY 5-HYDROXYINDOLEACETIC ACID WITH SPECIAL REFERENCE TO CASES WITH THYROID DISORDERS].
    CHIBA N.
    Tohoku Igaku Zasshi; 1963 May 30; 67():543-61. PubMed ID: 14159772
    [No Abstract] [Full Text] [Related]

  • 30. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine.
    MUSTAKALLIO KK, LEVONEN E, RAEKALLIO J.
    Science; 1961 Aug 04; 134(3475):344. PubMed ID: 13727138
    [Abstract] [Full Text] [Related]

  • 31. Reciprocal changes in striatal dopamine and beta-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors.
    Juorio AV, Greenshaw AJ, Wishart TB.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec 04; 338(6):644-8. PubMed ID: 3149722
    [Abstract] [Full Text] [Related]

  • 32. [Studies on the induction of hepatic tryptophan peroxidase oxidases in the rat by the action of reserpine].
    MAFFEI-FACCIOLI A, MORTARI A, SCAMAZZO T.
    Boll Soc Ital Biol Sper; 1961 Dec 31; 37():1261-4. PubMed ID: 14468205
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacological aspects of the unnatural amino acids and amines. Introductory remarks.
    Horita A.
    Fed Proc; 1971 Dec 31; 30(3):857-8. PubMed ID: 4324973
    [No Abstract] [Full Text] [Related]

  • 34. Possible relations of hypoglycaemia induced by mono-amine oxidase inhibition and angina pectoris.
    LEAK D, DORMANDY TL.
    Proc Soc Exp Biol Med; 1961 Dec 31; 108():597-600. PubMed ID: 14463230
    [No Abstract] [Full Text] [Related]

  • 35. A METHOD FOR THE DEMONSTRATION OF MONOAMINE-CONTAINING NERVE FIBRES IN THE CENTRAL NERVOUS SYSTEM.
    DAHLSTROEM A, FUXE K.
    Acta Physiol Scand; 1964 Mar 31; 60():293-4. PubMed ID: 14131843
    [No Abstract] [Full Text] [Related]

  • 36. BIOGENIC AMINES, BIOGENIC ALDEHYDES, AND ALCOHOL.
    FELDSTEIN A, HOAGLAND H, WONG K, FREEMAN H.
    Q J Stud Alcohol; 1964 Jun 31; 25():218-34. PubMed ID: 14161784
    [No Abstract] [Full Text] [Related]

  • 37. [Behavior of circulating and tissue eosinophils in rats after administration of reserpine associated with serotonin antagonists and after inhibition of monoamine oxidase activity].
    Capelli A, Jasonni V, Piccaluga A.
    G Clin Med; 1967 Jun 31; 48(6):645-55. PubMed ID: 5614475
    [No Abstract] [Full Text] [Related]

  • 38. [Biological changes during depressive states and their treatment].
    TISSOT R, GARRONE G, de AJURIAGUERRA.
    J Med (Oporto); 1960 Oct 15; 43():273-6. PubMed ID: 13777041
    [No Abstract] [Full Text] [Related]

  • 39. Tersavid (RO 4-1634), an amine oxidase inhibitor, for the treatment of angina pectoris. Up to 15 months follow-up study.
    WEISMAN SJ, WEISMAN SA.
    Dis Chest; 1961 Apr 15; 39():459-63. PubMed ID: 13784031
    [No Abstract] [Full Text] [Related]

  • 40. Soluble monoamine oxidase; its properties and actions on serotonin.
    WEISSBACH H, REDFIELD BG, UDENFRIEND S.
    J Biol Chem; 1957 Dec 15; 229(2):953-63. PubMed ID: 13502356
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.